Skip to main content
. 2010 May 30;2010:726207. doi: 10.1155/2010/726207

Table 1.

Baseline patient characteristics per study group.

SAP UAP AMI CON P-value
Total participants 30 30 30 30
Age (mean years ± SD) 63.6 (10.5) 65.3 (13.0) 59.5 (12.6) 65.0 (9.5) NS
Male (%) 28 (93.3) 16 (55.1) 24 (80.0) 19 (63.3) .004
Smoking (%) 7 (23.3) 5 (16.7) 13 (43.3) 4 (13.3) .034
Exercise (%) 14 (46.7) 15 (50.0) 8 (26.7) 22 (73.3) .004
Alcohol use (U/day ± SD) 0.7 (1.3) 0.4 (0.7) 0.5 (0.9) 1.3 (1.1) NS
Family history for CVD (%) 26 (86.7) 18 (60.0) 14 (46.7) 19 (63.3) .013
Diabetes (%) 3 (10.0) 7 (23.3) 1 (3.3) 3 (10.0) NS
Beta-blocker use (%) 30 (100.0) 15 (50.0) 12 (40.0) 5 (16.7) <.001
Statin use (%) 26 (86.7) 18 (60.0) 12 (40.0) 6 (20.0) <.001
Aspirin use (%) 13 (43.3) 14 (46.7) 12 (40.0) 1 (3.3) .001
Antidiabetica use (%) 2 (6.7) 5 (16.7) 1 (3.3) 3 (10.0) NS
Cholesterol level (mmol/L ± SD) 4.2 (1.0) 4.7 (1.3) 5.5 (1.1) 5.6 (1.3) <.001
HDL-C (mmol/L ± SD) 1.1 (0.2) 1.0 (0.2) 1.0 (0.2) 1.2 (0.4) NS
LDL-C (mmol/L ± SD) 2.1 (1.0) 3.0 (1.1) 3.9 (1.0) 3.6 (1.1) <.001
ALT (IU/L± SD) 34 (17) 31 (19) 37 (22) 26 (29) NS
AST (IU/L± SD) 26 (13) 30 (16) 99 (139) 22 (11) NS
Renal clearance (mL/min ± SD) 85.8 (29.7) 83.7 (28.2) 93.2 (20.1) 83.7 (26.4) NS
Systolic BP (mmHg ± SD) 131.0 (14.8) 141.3 (22.0) 129.7 (30.0) 132.2 (15.6) NS
Diastolic BP (mmHg ± SD) 76.6 (7.9) 77.5 (15.3) 73.8 (15.4) 82.8 (8.6) .001
Body mass index (kg/m2± SD) 26.4 (3.7) 25.8 (2.9) 27.1 (3.5) 26.4 (3.9) NS
Troponin-T (μg/L ± SD) 0.00 (0.00) 0.21 (0.13) 2.08 (0.73) 0.00 (0.00) .003
Creatine kinase (U/L) 154.0 (107.5) 148.3 (141.3) 639.6 (913.8) 116.1 (47.4) <.001

Exercise is defined as a significant rise in heart rate for more than 30 minutes and at least once a week. Abbreviations: (NS) nonsignificant parameters, standard deviation (SD), units (U), cardiovascular disease (CVD), and blood pressure (BP).